Lineage Cell Therapeutics Inc.

06/23/2026 | Press release | Distributed by Public on 06/23/2026 00:03

FORM 4-STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP - Alice Lin-Tsing Yu, M.D., Ph.D.

ליניאג' סל תרפיוטיקס אינק
.LINEAGE CELL THERAPEUTICS, INC
Corporation no: 876343
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 23/06/2026
www.isa.gov.il www.tase.co.il Reference: 2026-02-058771
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market: -1 Date of revision of form structure: 06/08/2024
Address: HARBOR BAY PARKWAY 1301 , ALAMEDA94502CALIFORNIA , U.S.ATel: 5105213390 , Fax: 5105213389
E-mail address: [email protected] Company site: biotimeinc.com

Previous names of reporting entity: .BIOTIME, INC

Name of the Signatory: Gerzi SHNEOR Ilan Position of Signatory in the reporting corporation: Legal Adviser Name of Employer Company: PEARL COHEN ZEDEK LATZER BARATZ
Address: Derech Menachem Begin 121 , Tel Aviv6701203Telephone: 03-3039000Facsimile: E-mail: [email protected]
Lineage Cell Therapeutics Inc. published this content on June 23, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 23, 2026 at 06:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]